Quetiapine Tablet, Extended Release
Product Images NDC 29300-310

This is the label for Quetiapine Extended Release tablets which comes in a pack of 60 tablets. The medication is to be taken once daily and should be stored between 20-25°C. The manufacturer is Unichem Laboratories Ltd. The label includes a warning to keep the medication out of reach of children and a reference to a pharmacist for further information. The is shaky and therefore some parts of text are unclear.*

This is a drug container label for Quetiapine Fumarate tablets, an extended-release drug manufactured by UNICHE Laboratories LTD and distributed by UNICHEM Pharmaceuticals (USA), INC. The label shows the drug's National Drug Code (NDC), its composition, warning not to split, crush, or chew the tablets, and to store them in a tight, light-resistant container in a cool and dry place. The label also provides information on proper dispensing and cautions on keeping the medication out of children's reach. The label includes manufacturing and expiry dates and names and addresses of the manufacturers and distributors.*

This is a description of a medication with the NDC 29300-310-16. It is an extended-release tablet containing 230.26mg of Quetiapine. It is a controlled substance that should not be split, crushed or chewed, and should be taken once daily. It is manufactured by UNICHE LABORATORIES LTD for UNICHEM PHARMACEUTICALS (USA), INC. It should be stored in a tight container at 20°C to 25°C with excursions permitted between 15° to 30°C. The accompanying medication guide should be dispensed to each patient, and the medication should be kept out of reach of children.*

This text describes a medication called Quetiapine Extended-Release Tablets that should be taken once daily and stored in a tight, light-resistant container at a temperature between 20°C to 25°C (68°F to 77°F). The medication should not be crushed, split, or chewed. The accompanying prescribing information and medication guide should be given to each patient by the pharmacist. The medication is manufactured by Unichem Pharmaceuticals (USA) Inc. and the tablets are dispensed in a container as defined in the USP. The text also includes warnings to keep this medication out of reach of children.*

This is a medication description for Quetiapine Extended-Release Tablets, USP. Each extended-release tablet contains 460.52mg of Quetiapine Fumarate USP equivalent to 10400 mg of Quetiapine. The tablets should be swallowed whole and not split, crushed, or chewed. The recommended dosage is once daily as per the accompanying prescribing information. The medication should be stored in a tight, light-resistant container defined in the USP and kept at a controlled room temperature between 20°C to 25°C (68°F to 77°F), with excursions permitted between 15° to 30°C (S to 86°F). The medication should be kept away from children. The medication comes in a container of 60 tablets and includes an accompanying medication guide for each patient. Manufactured by UniChem Laboratories LTD in India and manufactured for UniChem Pharmaceuticals (USA), Inc. in East Brunswick, NJ, USA.*